Xing-ru Zhang
Wenzhou, 325000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Neuroprotective effects of curcumin via autophagy induction in 6-hydroxydopamine Parkinson's models.
Neuroprotective effects of curcumin via autophagy induction in 6-hydroxydopamine Parkinson's models.
Journal: Neurochemistry international
Published: October 17, 2021
The Advantages of Levodopa-Carbidopa Intestinal Gel for Patients with Advanced Parkinson's Disease: A Systematic Review.
Journal: Drug design, development and therapy
Published: September 02, 2019
β-arrestin2 alleviates L-dopa-induced dyskinesia via lower D1R activity in Parkinson's rats.
Journal: Aging
Published: September 01, 2019
Striatal overexpression of β-arrestin2 counteracts L-dopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson's disease rats.
Journal: Neurochemistry international
Published: July 11, 2019
Levodopa/Benserazide PLGA Microsphere Prevents L-Dopa-Induced Dyskinesia via Lower β-Arrestin2 in 6-Hydroxydopamine Parkinson's Rats.
Journal: Frontiers in pharmacology
Published: October 12, 2018
Modulation of CaMKIIa-GluN2B interaction in levodopa-induced dyskinesia in 6-OHDA-lesioned Parkinson's rats.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 22, 2018
Effects of mGluR5 Antagonists on Parkinson's Patients With L-Dopa-Induced Dyskinesia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Journal: Frontiers in aging neuroscience
Published: September 20, 2017
An Overview of Meta-Analyses of Endovascular Bridging Therapies for Acute Ischemic Stroke.
Journal: BioMed research international
Published: July 22, 2017
A Meta-Analysis of Adenosine A2A Receptor Antagonists on Levodopa-Induced Dyskinesia In Vivo.
Journal: Frontiers in neurology
Published: December 08, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026